SUV39H2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.907600E-01
Normal-vs-Stage2
8.892000E-01
Normal-vs-Stage3
1.549020E-01
Normal-vs-Stage4
5.395000E-01
Stage1-vs-Stage2
3.547200E-01
Stage1-vs-Stage3
1.002010E-01
Stage1-vs-Stage4
7.809200E-01
Stage2-vs-Stage3
1.720640E-01
Stage2-vs-Stage4
6.728800E-01
Stage3-vs-Stage4
8.793800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.112800E-01
Normal-vs-AfricanAmerican
5.498600E-01
Normal-vs-Asian
8.117800E-01
Caucasian-vs-AfricanAmerican
4.281000E-01
Caucasian-vs-Asian
6.059200E-01
AfricanAmerican-vs-Asian
2.383200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.844000E-01
Normal-vs-Female
8.324200E-01
Male-vs-Female
3.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.415600E-01
Normal-vs-Age(41-60Yrs)
6.426600E-01
Normal-vs-Age(61-80Yrs)
9.135200E-01
Normal-vs-Age(81-100Yrs)
7.495600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.605000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.168600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.271200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.898400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.810800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.295400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.429800E-01
Normal-vs-Daily Drinker
7.411800E-01
Normal-vs-Weekly Drinker
6.236600E-01
Normal-vs-Occasional Drinker
8.596000E-01
Normal-vs-Social Drinker
9.243600E-01
Non Drinker-vs-Daily Drinker
6.480600E-01
Non Drinker-vs-Weekly Drinker
2.289600E-01
Non Drinker-vs-Occasional Drinker
6.665800E-01
Non Drinker-vs-Social Drinker
9.949000E-01
Daily Drinker-vs-Weekly Drinker
1.756610E-01
Daily Drinker-vs-Occasional Drinker
3.377800E-01
Daily Drinker-vs-Social Drinker
6.408800E-01
Weekly Drinker-vs-Occasional Drinker
4.175800E-01
Weekly Drinker-vs-Social Drinker
2.861800E-01
Occasional Drinker-vs-Social Drinker
6.411600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.390000E-01
Normal-vs-Grade 2
7.808000E-01
Normal-vs-Grade 3
7.953600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.976600E-01
Grade 1-vs-Grade 3
1.673360E-01
Grade 1-vs-Grade 4
7.390000E-01
Grade 2-vs-Grade 3
6.459400E-01
Grade 2-vs-Grade 4
7.808000E-01
Grade 3-vs-Grade 4
7.953600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.123800E-01
Normal-vs-NonDiabetic
9.695800E-01
Diabetic-vs-NonDiabetic
2.867800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.199200E-01
Normal-vs-NoPancreatitis
9.649200E-01
Pancreatitis-vs-NoPancreatitis
4.944000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.108400E-01
Normal-vs-N1
8.798000E-01
N0-vs-N1
7.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.525000E-01
Normal-vs-TP53-NonMutant
7.260200E-01
TP53-Mutant-vs-TP53-NonMutant
2.575800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
